Page Added: Onglyza - Just Like Januvia, but Worse
Added review of FDA required Prescribing Information for newly approved DPP-4 inhibitor, Onglyza. Text of page is the same as August 3 Diabetes Update blog post on same topic.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment